Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...

Unfortunately, that's been the case for longer term Pfizer Inc. (NYSE:PFE) shareholders, since the share price is down 55% in ...

With its stock down 7.6% over the past three months, it is easy to disregard Pfizer (NYSE:PFE). We, however decided ...

Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells ...

The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of ...

Pfizer CEO says tariffs are discouraging the company from investing in the US. Pfizer's full-year guidance does not factor in ...

Schonfeld Strategic Advisors LLC lowered its stake in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 82.7% during the 4th ...

Pfizer still has another obesity pill in development, PF-07976016, which is currently in a Phase IIa trial. Pfizer has terminated the development of its oral obesity candidate danuglipron after a ...

Get insights into Pfizer's Q1 earnings, including challenges like patent expiries & pricing controls, and discover why ...

Shares in 5,432 companies trade every day starting at 9:30 on the New York Stock Exchange or Nasdaq ... week’s respective drops of 17% and 18%. Pfizer fell another 1% Monday, for a total ...